Register Education Students Posters Resources Engage Destination Supporters #StigmaFree

Creative and Collaborative - Pharmacists on the Front-line of Medication Assisted Treatment for Opioid Use Disorder

Sunday, Apri1 22, 2018, 7:45-11:30 AM
ACPE Approved for 3.5 Contact Hours

Pharmacists are often an underutilized health care resource despite their medication expertise and accessibility. Pharmacists are essential health care providers who are trained to recognize opioid overdose, opioid use disorder, and withdrawal syndromes.

Integration of the pharmacist into medication assisted treatment (MAT) teams for opioid use disorders can help improve access and outcomes, while reducing the risk of relapse. When pharmacists partner with prescribers to provide MAT, pharmacists are able to take the lead in identifying treatment options, developing treatment plans, communicating with patients, improving adherence, monitoring patients, and performing tasks to alleviate prescriber burden.

This session will showcase different practice settings where psychiatric pharmacists partner with prescribers to provide collaborative care for patients with substance use disorders. The learner will leave with knowledge of innovative ways to include pharmacists on the MAT interprofessional team and how to design and execute effective practice protocols. In addition, the learner will explore the pharmacist’s role in addressing controversies and challenges in providing MAT with regard to state and federal level limitations.

Pharmacists participating in this program will be able to:

  1. Evaluate the need and capacity for medication assisted treatment for opioid use disorder on the state and national levels.
  2. Compare outcomes from collaborations integrating pharmacists in the medication assisted treatment care team in different practice settings across the United States.
  3. Describe the barriers and benefits encountered in establishing a collaborative practice agreement with prescribers to provide medication assisted treatment.
  4. Engage legislators, state administrators, and professional organizations to promote the role of pharmacists in medication assisted treatment. 

Agenda

7:45-9:45 AM

  • Welcome and Introductions
  • The Need and Capacity of Medication Assisted Treatment for Opioid Use Disorder on the State and National Levels
  • Panel Discussion

9:45-10:00 AM

  • Break

10:00-11:30 AM

  • Active Learning
  • Engaging Government, Professional Organizations, and Boards of Medicine and Pharmacy to Promote the Role of Pharmacists in MAT
  • Active Learning
  • Conclusions and Questions

Registration Fees*

Registration is available at cpnp.org/register Registration Fee
Member $115
Non-member $140
Resident/Fellow-Member $99
Resident/Fellow-Non-member $124
Student-Member $99
Student-Non-member $124

Registration Includes

  • Workshop content and 3.5 contact hours of ACPE credit
  • Coffee break
  • Practical, take-home materials and tools
*Early registration fees are available through March 22, 2018. After March 22, 2018, registration fees increase. 

 

Faculty Information and Disclosures

Sarah Melton, PharmD, BCPP, BCACP, FASCP
Pre-Meeting Workshop Chair

Sarah T. Melton is Professor of Pharmacy Practice at the Gatton College of Pharmacy at East Tennessee State University (ETSU). She is the Clinical Pharmacist at the Johnson City Community Health Center, the ETSU Center of Excellence for HIV/AIDS, and Highpower, PC. Dr. Melton received her Bachelor of Science in Pharmacy (1991) and Doctor of Pharmacy (1994) degrees from Virginia Commonwealth University/Medical College of Virginia School of Pharmacy (VCU). She completed a Fellowship in Psychiatric Pharmacy at VCU in 1996. She performs comprehensive medication management (CMM) in the areas of psychiatric and neurologic pharmacy, addiction, and other primary care disorders. Melton is recognized nationally for her work in substance abuse most recently with the APhA Generation Rx Award of Excellence acknowledging her commitment to the mission of substance abuse education.
 
No Relevant Financial Relationships to Disclose
Christopher M. Jones, PharmD, MPH
Director of the National Mental Health and Substance Use Policy Laboratory
US Department of Health and Human Services
 

No Relevant Financial Relationships to Disclose

Ray Love, PharmD, BCPP, FASHP
Professor of Pharmacy
Vice Chair for the Department of Pharmacy Practice and Science
Director Mental Health Program
University of Maryland

External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: APhA Workgroup on Medication Administration, NASPA-CPNP Panel on LAIs
Major Stock Shareholder: miscellaneous pharmaceutical stocks controlled by a third party
 

Troy Moore, PharmD, MS, BCPP
Clinical Pharmacy Specialist/Assistant Professor
STVHCS/University of Texas HSC San Antonio

No Relevant Financial Relationships to Disclose

Bethany DiPaula, PharmD, BCPP
Associate Professor, University of Maryland
Director of Pharmacy, Springfield Hospital Center

No Relevant Financial Relationships to Disclose

Gayle Callahan, PharmD, BCPP
Substance Use Disorder/Mental Health Consultant Pharmacist
Operation PAR/Diversified Consultant Pharmacists